Clinical Guest Contributors

  1. Can't-Miss Advice On Selecting Your First AI-Enabled Vendor 12/12/2025

    Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.

  2. Clinical Supply's Role In Driving Success In Decentralized Trials 12/11/2025

    Decentralized trials are a challenge for supply chain professionals. Explore how logistics, labeling, and home delivery make or break trial outcomes.

  3. The 2020 Pediatric Mandate That Shook Up Oncology Research 12/11/2025

    Until 2020, the majority of drugs used in pediatric medicine had not been studied adequately in children. Regulatory expert Bhargavi Pandit recounts the impact the U.S. RACE for Children Act had on pediatric and adult investigational drug trials.

  4. The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity 12/10/2025

    Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry. 

  5. Overcoming Cell Therapy Design Challenges To Treat AML And Other Life-Threatening Diseases 12/9/2025

    CERo CEO Chris Ehrlich discusses how a focus on safety, robust manufacturing, and key early indicators is rewriting the playbook for future personalized medicine trials.

  6. Takeda Keeps Patients The Focus Of PDTs For Rare Disease 12/9/2025

    Takeda’s Kristina Allikmets, MD, Ph.D, shares how her team incorporates patient voices and prioritizes innovations to reduce treatment burden, expand access, and develop plasma-derived therapies for rare diseases.

  7. Designing Patient-Centric Recruitment Pathways With Real-Time Adherence Insights 12/8/2025

    Learn how digital adherence solutions can enable real-time monitoring and site-level oversight to improve patient engagement and protocol compliance.

  8. Navigating The Challenges Of Cell Therapy Clinical Trials 12/5/2025

    IN8bio CEO William Ho shares how they overcame operational challenges unique to cell therapy research, including how to carefully conduct site expansion and onboard new sites without disrupting study timelines.

  9. Patient Input Is A Must — Even Under Time And Money Constraints 12/4/2025

    Stacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.

  10. From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials 12/3/2025

    Discover how pharma R&D is moving from traditional compute clusters to AI-driven HPC ecosystems and hybrid architectures that combine on-premise supercomputing with elastic cloud infrastructure.